μ-阿片系统在特应性皮炎表皮中的表达及作用初探  

A preliminary study on the expression and function of μ-opioid system in the epidermis of patients with atopic dermatitis

作　　者：陈洁[1] 石梅[1] 郭一峰[1] 姚志荣[1] 

机构地区：[1]上海交通大学医学院附属新华医院皮肤科,200092

出　　处：《中华皮肤科杂志》2010年第10期709-712,共4页Chinese Journal of Dermatology

基　　金：上海市科委科研计划项目（08JC1415900）

摘　　要：目的 探讨μ-阿片系统在特应性皮炎表皮中的表达及其在发病中的作用.方法 以特应性皮炎模型鼠为研究对象,分为阴性对照组、治疗前组、纳洛酮组、0.9%氯化钠溶液组4个组.采用荧光定量PCR法,对纳洛酮（μ-阿片受体拮抗剂）治疗前后小鼠表皮的μ-阿片受体及其配体β-内啡肽的mR-NA的表达进行研究,同时对治疗前后小鼠皮损严重度评分及病理进行比较.结果 特应性皮炎模型鼠在治疗前表皮的μ-阿片受体的表达较正常小鼠明显下调（t=2.549,P＜0.05）,经纳洛酮治疗后其μ-阿片受体的表达重新上调,与正常小鼠的表达差异无统计学意义（t=0.671,P＞0.05）.表皮的β-内啡肽的表达在正常小鼠及特应性皮炎模型鼠的治疗前后差异均无统计学意义（P均＞0.05）.经纳洛酮治疗后,特应性皮炎模型鼠的皮损严重度评分较治疗前明显下降（t=8.338,P＜0.01）,并与病理学改变一致.结论 纳洛酮作为一种μ-阿片受体拮抗剂,对特应性皮炎具有一定疗效,能使特应性皮炎模型鼠表皮μ-阿片受体的表达恢复正常,证明μ-阿片系统与特应性皮炎的发病机制存在着一定关系.Objective To investigate the expression of μ-opioid system in the epidermis of patients with atopic dermatitis and its role in the pathogenesis of atopic dermatitis. Methods Thirty-two mice were equally divided into 4 groups, negative control group, pre-treatment group, naloxone group, and physiological saline group. Ovalbumin was used to sensitize mice in pretreatment group, naloxone group, and physiological saline group for 7 weeks, then, mice in naloxone group and physiological saline group were treated with intracutaneous naloxone or physiological saline solution for 1 week, respectively. Mice were killed in negative control group and pre-treatment group at the end of sensitization, and in naloxone group and physiological saline group after 1-week injection with naloxone or physiological saline, skin tissues were obtained from the back of killed mice and subjected to histological examination with HE staining and quantitative fluorescent PCR for the detection of mRNA expression of μ-opioid receptor （MOR） and its ligand （β-endorphin） in epidermis. The atopic dermatitis severity index of lesions and histological changes were assessed before and after the treatment. Results In comparison with the negative control mice, the epidermal expression level of MOR was signifieantly decreased （t = 2.549, P 〈 0.05 ） in pre-treatment group, but increased in naloxone group and showed no statistical difference from the negative control group （t = 0.671, P 〉 0.05）. No significant difference was observed in the epidermal β-endorphin mRNA expression between negative control group and pre-treatment group or naloxone group （both P 〉 0.05 ）. The improvement of lesions could be visualized after treatment with naloxone （t = 8.338, P 〈 0.01 ）, which was concordant with the histological changes in naloxone group. Conchusions As an antagonist of MOR, naloxone can restore the expression of epidermal MOR in mice model for atopic dermatitis, and shows a certain efficacy in the treatment of atopic dermati

关 键 词：皮炎 特应性 受体 阿片样 μ 纳洛酮 

分 类 号：R758.2[医药卫生—皮肤病学与性病学]